Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Abstract Background Transarterial chemoembolization (TACE) is recommended as the standard care for unresectable hepatocellular carcinoma (HCC) at Barcelona Clinic Liver Cancer (BCLC) stage A–B. However, the efficacy of TACE on large (≥ 10 cm) stage A–B HCC is far from satisfactory, and it is propose...

Full description

Bibliographic Details
Main Authors:	Min-Ke He, Yong Le, Qi-Jiong Li, Zi-Shan Yu, Shao-Hua Li, Wei Wei, Rong-Ping Guo, Ming Shi
Format:	Article
Language:	English
Published:	BMC 2017-10-01
Series:	Chinese Journal of Cancer
Subjects:	Hepatocellular carcinoma Hepatic artery infusion chemotherapy Transarterial chemoembolization mFOLFOX
Online Access:	http://link.springer.com/article/10.1186/s40880-017-0251-2

Similar Items

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma
by: Zhiyuan Cai, et al.
Published: (2021-04-01)

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
by: Mototsugu Matsunaga, et al.
Published: (2016-04-01)

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
by: Mototsugu Matsunaga, et al.
Published: (2016-04-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
by: Shao W, et al.
Published: (2019-11-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases
by: Shuai Wang, et al.
Published: (2019-01-01)

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)
by: Keisuke Miwa, et al.
Published: (2021-01-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
by: Taku Naiki, et al.
Published: (2017-11-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
by: Lei Zhang, et al.
Published: (2020-09-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
by: Yashwant Patidar, et al.
Published: (2021-04-01)

Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Lin Li, et al.
Published: (2018-09-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Assessment of the relationship between hepatocellular carcinoma location and its response to transarterial chemoembolization
by: Ahmed Elsahhar, et al.
Published: (2021-09-01)

Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma
by: Xiang Li, et al.
Published: (2020-11-01)

Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
by: Yashwant Patidar, et al.
Published: (2019-04-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient
by: Hsaing-Hung Lin, et al.
Published: (2014-09-01)

Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study
by: Tang CW, et al.
Published: (2016-08-01)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
by: Yue-Lin Zhang, et al.
Published: (2020-09-01)

Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score‐matching cohort study
by: Wenbo Guo, et al.
Published: (2020-06-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Mingyu Chen, et al.
Published: (2021-01-01)

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake
by: Osumi H, et al.
Published: (2018-11-01)

Clinical effects and prognosis of stereotactic body radiotherapy combined with transarterial chemoembolization for massive hepatocellular carcinoma
by: Jun Pang, et al.
Published: (2021-03-01)

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
by: Dominik Bettinger, et al.
Published: (2017-08-01)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01)

SIB-IMRT combined with apatinib for unresectable hepatocellular carcinoma in patients with poor response to transarterial chemoembolization
by: Liu, X., et al.
Published: (2022)

Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization
by: Li S, et al.
Published: (2021-02-01)

Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
by: Tian-Cheng Wang, et al.
Published: (2021-03-01)

Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection
by: Jiashuo Chao, et al.
Published: (2021-03-01)

Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Wang H, et al.
Published: (2020-05-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
by: Mohammad Arabi, et al.
Published: (2015-01-01)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
by: Zhang YF, et al.
Published: (2016-07-01)